When spinal roots are torn off from the spinal cord, both the peripheral and central nervous system get damaged. As the motoneurons lose their axons, they start to die rapidly, whereas target muscles atrophy due to the denervation. In this kind of complicated injury, different processes need to be targeted in the search for the best treatment strategy. In this study, we tested glial cellderived neurotrophic factor (GDNF) treatment and fetal lumbar cell transplantation for their effectiveness to prevent motoneuron death and muscle atrophy after the spinal root avulsion and delayed reimplantation. Application of exogenous GDNF to injured spinal cord greatly prevented the motoneuron death and enhanced the regeneration and axonal sprouting, whereas no effect was seen on the functional recovery. In contrast, cell transplantation into the distal nerve did not affect the host motoneurons but instead mitigated the muscle atrophy. The combination of GDNF and cell graft reunited the positive effects resulting in better functional recovery and could therefore be considered as a promising strategy for nerve and spinal cord injuries that involve the avulsion of spinal roots.
INTRODUCTION
Accidents and trauma can often cause damage to the nervous system, with injuries ranging from mild crush injuries to severe spinal cord injuries (1) (2) (3) (4) . These injuries can result in total or partial loss of motor and/or sensory functions. Although peripheral nerve injuries are relatively easier to treat as peripheral nerves are able to regenerate (4, 5) , it is unfortunate that many of the traumas (e.g. spinal cord injuries and brachial plexus injuries) can also damage the central nervous system (CNS) and the peripheral nervous system (PNS) (1, 2, 6) . A commonly studied injury model to resemble brachial plexus injury is a root avulsion model, where spinal roots are torn off from the spinal cord, causing the death of motoneurons in the spinal cord and degeneration of the peripheral nerve (7) . With this kind of complex injury, different combination strategies that would promote motoneuron survival, axonal regeneration and also prevent the muscle atrophy should be considered.
As a good surgical treatment for avulsion injuries, reimplantation of ventral roots has been shown to effectively facilitate axonal regeneration into the nerve (8, 9) . If ventral roots are already damaged, the implantation of a peripheral nerve graft can be considered. However, the axonal regeneration has shown to be much better after ventral root reimplantation compared to peripheral nerve graft implantation (8) . However, even in the case of immediate repair, motoneurons still tend to die after the initial injury, and still more die when the repair is delayed; therefore, the longer the delay in spinal root reimplantation, the fewer surviving motoneurons remain that can regenerate their axons into the spinal nerve. Unfortunately, surgeries cannot always be performed quickly and there is usually some delay between the time of injury and the surgery. Therefore, if the delay between the injury and surgery is 2 or more weeks, the outcomes with only surgical repair can be relatively poor and some other early interventions to keep the motoneurons alive for a longer time should be considered.
Two potential neurotrophic factors, brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF), have been shown to prevent motoneuron death after the avulsion and keep approximately 80%-90% of motoneurons alive for at least 6 weeks (10) (11) (12) (13) (14) . This treatment should be done within 2 weeks and most effectively within 3 days from the injury because the motoneurons are then still alive and neurotrophic factor receptors are upregulated (11, 12, 15) . From the neurotrophic factors that have been studied, GDNF is the most promising in helping motoneurons survive, as even a single topical application to the spinal cord is sufficient (11) . The mechanisms by which BDNF and GDNF promote the motoneuron survival are suggested to be through inhibition of neuronal nitric oxide synthase and upregulation of c-Jun and P75 (10) . If GDNF helps motoneurons survive for at least 6 weeks, it allows a longer delay in the surgical treatment. In this study, a combination of immediate single dose GDNF treatment along with 2-week delayed ventral root reimplantation was used to determine whether motoneurons that have been prevented from cell death by GDNF are still able to regenerate into the spinal root and regrow further after delayed repair.
Neurotrophic factor treatment and surgical repair have been shown to be effective in promoting motoneuron survival and regeneration after avulsion injuries, but they do not show much effect on muscle atrophy or functional recovery (9, 10, 14, (16) (17) (18) (19) (20) (21) . However, if the injury happens distally, as in the case of avulsions, the distance between the injury site and target muscles is very long, resulting in severe muscle atrophy even when the surgical repair is performed early. Several strategies have been applied to prevent muscle atrophy: 1) manipulating pathways involved in muscle atrophy (22) (23) (24) (25) (26) (27) (28) (29) , 2) neurotization (30-37), 3) functional electrical stimulation of the muscle (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) , and 4) neuronal replacement by cell transplantation (55) (56) (57) (58) (59) (60) (61) (62) (63) . For the latter, only cells able to differentiate into motoneurons (e.g. neural progenitor cells, embryonic stem cells, induced pluripotent stem cells, and early neuronal cells) should be considered because motoneurons are the only cells able to form connections with muscle fibers. Our previous study showed that fetal spinal cord (FSC) cells, particularly lumbar cells, can prevent muscle atrophy after peripheral nerve transection (64) , and thus this strategy was also applied here. The hypothesis is that if the cells are injected distally, they will reach the target muscles before the host axons and help preserve the muscle endplates and muscles. We hypothesized that the combination of ventral roots reimplantation, GDNF treatment, and cell transplantation will have better functional outcome compared to the individual approaches.
MATERIALS AND METHODS

Animals
Sprague-Dawley (SD) female rats (220-250 g body weight) were used for breeding and surgeries and were ordered from the Laboratory Animal Unit of the University of Hong Kong. All procedures involving the use of live animals were approved by the Committee for the Use of Live Animals in Teaching and Research (CULATR 3735-15) at the University of Hong Kong.
Preparation of Cells
FSCs were isolated from E14.5 green fluorescent protein (GFP)-expressing embryos (SD-Tg(CAG-EGFP)CZ004Osb "green rat" strain from SLC, Shizuoka, Japan) and prepared for transplantation. Shortly thereafter, a pregnant female was killed by the overdose of CO 2 , the uterus was dissected out, and GFP-expressing embryos were identified. Under an operating microscope, spinal cords were separated from the surrounding tissues and meninges were peeled off. The lumbar spinal cord was isolated and transferred separately into a 15-mL centrifuge tube containing Hanks' balanced salt solution ([HBSS] , Invitrogen, Carlsbad, CA), and centrifuged at 700 rpm for 3 minutes. Tissues were washed with HBSS and 1 mL of 0.15% Trypsin (Invitrogen) was added to the tube and incubated at 37 C for 7 minutes; 0.5 mL of trypsin inhibitor (10 mg/mL soybean powder in HBSS, Gibco, Waltham, MA) was added to stop the trypsin reaction before the cells were spun down at 1400 rpm for 3 minutes. The cells were again washed with HBSS, spun down at 1200 rpm for 3 minutes and resuspended in 2 mL of Dulbecco's modified Eagle's medium (DMEM/F12, Gibco). Single cell suspension was achieved by pipetting the cells 20 times with a bigger pipette tip and then 20 times with a smaller tip. Trypsin blue and hemocytometer were used to assess the cell survival and count the cell numbers and the cells were then spun down once more. Cells were resuspended in DMEM/F2 without supplements to achieve a final concentration of 10 5 cells/mL and used for the transplantation on the same day.
Immunocytochemistry
For in vitro characterization of fetal lumbar cells, some were seeded onto laminin and Poly-DL-ornithine (both SigmaAldrich, St. Louis, MO)-coated coverslips (ø13 mm, Thermo Scientific, Waltham, MA) with "neural medium" (DMEM/F12, 2% B27, 1% N2, 1% NEAA, all from Invitrogen) (5 Â 10 4 cells/ coverslip) immediately following embryonic spinal cord dissociation into single-cell culture. Cells were incubated overnight and then fixed in 4% paraformaldehyde (PFA) dissolved in 0.1 M phosphate buffer (PB) for 10 minutes and washed with phosphate buffered saline (PBS) several times. The following primary antibodies in 1% bovine serum albumin (Sigma-Aldrich), 0.1% Triton X-100 (Sigma-Aldrich) in PBS were used to stain the cells: mouse anti-b-III-tubulin (1:1000, SigmaAldrich) and mouse antineurofilament H (SMI-31, 1:1000, Covance, Princeton, NJ) for neurons, and rabbit anti-HoxD10 (1:5000, Abcam, Cambridge, UK) for identifying subtype of cells from lumbar segment. The cells were incubated with primary antibodies overnight at 4 C. Then, coverslips were washed 3 times with PBST (PBS containing 0.2% Tween-20 [Sigma-Aldrich]) and incubated with species-specific secondary antibodies conjugated to the fluorescent label Alexa 568 or 488 (1:500, Invitrogen) for 1 hour at room temperature. After 3 more washes with PBST, the cells were counterstained with DAPI (4 0 , 6-diamidino-2-phenylindole) for 5 minutes at room temperature to visualize nuclei, washed again in PBS, and mounted in antifade mounting medium (Dako, Glostrup, Denmark). The images were taken with a fluorescent microscope (Zeiss Axioplan, Zeiss, Oberkochen, Germany).
Animal Surgery
The animals were anesthetized with an intraperitoneal injection of ketamine (80 mg/kg) and xylazine (10 mg/kg).
Under surgical microscope, the cut was made on the dorsal back through the muscle layers till the spine segments from the fifth cervical (C5) to first thoracic (T1) lamina were exposed. During the surgery, local anesthetic lidocaine was applied when needed and gelfoam was used to stop excessive bleeding if needed. A dorsal laminectomy was performed on the laminae C5-C7 on the right side and dura matter was opened with microscissors to expose the spinal roots C5-C7. Then, dorsal spinal roots of C5-C7 were cut with microscissors and ventral roots were avulsed from the spinal cord using a fine glass hook. C5 and C7 spinal roots together with part of their spinal nerves were cut and removed, leaving a gap between the spinal cord and nerves to prevent any reinnervation from these spinal roots. The animals were then divided into 6 different groups (8 animals per group) as follows: 1) G1 group (avulsion only), 2) G2 group (avulsion þ immediate reimplantation), 3) G3 group (avulsion þ delayed reimplantation), 4) G4 group (avulsion þ delayed reimplantation þ GDNF), 5) G5 group (avulsion þ delayed reimplantation þ cells), and 6) G6 group (avulsion þ delayed reimplantation þ GDNF þ cells).
For the G1 group, C6 roots and spinal nerve were cut away the same way as C5 and C7. For the G2 group, dorsal spinal roots of the C6 were cut shorter and ventral roots were immediately reimplanted to the spinal cord. For reimplantation, C6 ventral roots were placed ventrolaterally to the pia mater of the ventral spinal cord. For G3-G6 groups, dorsal spinal roots of the C6 were cut shorter and ventral roots were ligated with silk suture and kept away from the spinal cord until the delayed reimplantation 2 weeks later. For the groups G4 and G6, gelfoam soaked in 2 lL of GDNF (2 mg/lL) (PeproTech, Rehovot, Israel) was placed topically on the avulsed C6 spinal cord segment. Any kind of spinal cord injury was avoided during the surgery by careful handling. In the end, the muscles and fascia were closed with 5-0 Ethilon nylon sutures, and the skin was closed with wound clips.
For the G5 and G6 groups, cell transplantation into musculocutaneous nerve was done immediately after the animals were closed from the back side after the avulsion injury. For cell transplantation, animals were placed in supine position and a cut was made to their right thorax to expose the musculocutaneous nerve. One microliter of lumbar FSC cells (10 5 cells/mL) was injected through a syringe connected to the glass micropipette into the distal part of the musculocutaneous nerve close to the site where the nerve enters the biceps brachii muscle. Muscles and skin were then closed using 5-0 and 3-0 sutures, respectively.
Two weeks after the first surgery, animals from the groups G3-G6 underwent the delayed reimplantation surgery. They were again anesthetized and opened from the back side as described above. Muscle layers were cut and an excessive amount of connective tissue was carefully removed in order to expose the injury site. Ligated C6 roots were tracked and carefully cut away from the other surrounding tissues. Scar tissue together with the gelfoam was carefully removed from the spinal cord C6 segment to make enough space for the roots to be reimplanted. Ligation on C6 ventral roots was removed and roots were cut a bit shorter and the C6 ventral roots were placed ventrolaterally on the pia mater of the ventral spinal cord to allow the regeneration of motoneurons into the reimplanted root. The muscles were sutured and the skin was closed with the wound clips.
All the animals were allowed to survive a total of 14 weeks after the first injury (12 weeks after the delayed reimplantation surgery). All the surgical procedures with the timeline and animal groups are visualized in Figure 1 .
Terzis Grooming Fest
For functional recovery assessment, Terzis grooming test was performed. Animals were tested once right after the injury, once right before and after the repair, and weekly from postrepair week 3. In the test, water was poured over the animal's head to elicit grooming movements of the forepaws toward the head. In normal grooming, the animal raises both forelimbs, licks them, and reaches the area behind the ears. A common grading scale described by Gu et al was used: 0-no response; 1-flexion at the elbow, not reaching the snout; 2-flexion reaching the snout; 3-reaching below the eyes; 4-reaching to the eyes; and 5-reaching to the ears and beyond (17) . For data representation, time-course recovery of average scores and the average scores for final time point are shown. In addition, numbers of animals with each score at 2 different time points (9 and 12 weeks after reimplantation) are shown as stacked column graphs.
Electromyographic Measurements
Electromyographic (EMG) testing was performed 3-5 days before the final time point because, at that time, animals were anesthetized and opened to receive FluoroGold (FG) injection into the musculocutaneous nerve. Because the nerve is also crushed during the FG injection, EMG had to precede the FG injection. A bipolar stimulating electrode was placed under the intact musculocutaneous nerve proximal to the cell graft (if any), while 2 recording electrodes were inserted into the middle of the muscle belly of the biceps brachii with a space of approximately 1-2 mm between them. At least 3 different locations in the biceps were chosen and the forelimb movement and response amplitude were recorded. The same positive stimulating current (5Â 1 V, 0.2 ms) was used in all animals. EMG signals were collected with a multichannel signal acquisition and processing system (RM6240BD, Chengdu, China). The mean EMG amplitude for each experimental group was calculated as an average of the highest amplitudes in each animal and response delay at maximum response amplitude was measured and was shown as the average delay. One animal from group G4 did not have any response (0 mV) and therefore response delay could not be measured. Also, during the EMG recordings from 1 animal in the G2 group, the electrodes were not working properly and we were not able to get a response (not even the stimulus artifact) and this animal was therefore excluded from EMG assessment. The normal baseline EMG response and delay for the same stimulus were recorded from the left noninjured side of 20 animals.
Retrograde Labeling With FG
Three to 5 days before the death, the animals were anesthetized with an intramuscular injection of ketamine (80 mg/kg) and xylazine (8 mg/kg). Three animals, 1 from each group G2-G4, did not get FG injection and therefore the lower "n" number is seen in these groups. Musculocutaneous nerve and biceps brachii were exposed and 0.8 mL of 6% FG was slowly injected into the musculocutaneous nerve at a site 1 cm proximal to the muscle in a direction toward the spinal cord. The injection was made with a fine glass micropipette. After the injection, the nerve was slightly crushed to prevent any leakage and to enhance the FG uptake by damaged axons. Animals were closed as described previously and allowed to survive 3-5 days before they were killed.
Tissue Processing
At the final time point, animals were anesthetized with pentobarbitone (50 mg/kg) and perfused intracardially with 0.9% saline followed by 4% PFA solution in 0.1 M PB. The C5-C7 spinal cord was carefully harvested together with the reimplanted roots. In addition, both left and right musculocutaneous nerve and biceps brachii muscle were harvested and the muscles were weighed on a laboratory scale. The percentage of retained muscle weight was calculated for each animal by dividing the wet weight of right side muscle with the weight of left noninjured side muscle. All tissues were FIGURE 1. Injury model. (A) Dorsal roots of C5, C6 and C7 were cut and ventral roots were torn away from the spinal cord. Gelfoam soaked in GDNF was placed on the C6 spinal cord injury site in groups G4 and G6. For group G2, C6 ventral roots were reimplanted immediately to the spinal cord, whereas in G3-G6 groups, reimplantation was done 2 weeks after the initial injury. In groups G5 and G6, animals were opened from the front side right after the avulsion injury, and 1 lL of lumbar FSC cells was injected into the musculocutaneous nerve close to the muscle entering site. (B) Timeline of the experimental procedures on animals. Animals were kept 12 weeks after the delayed reimplantation (14 weeks for groups G1 and G2), whereas FG injection and EMG were performed 3-5 days before the perfusion. (C) Animal treatment groups.
postfixed in 4% PFA solution overnight and stored in 30% sucrose in 0.1 M PB solution at 4 C for at least 3-4 days. Next, all the tissues were embedded in Tissue-Tek O.C.T. (Sakura, Leiden, The Netherlands) and cut using a Leica CM1980 cryostat (Leica, Wetzlar, Germany) for immunohistochemical and hematoxylin and eosin staining. The nerve and muscle tissues were cut transversely or longitudinally at 8 mm, whereas spinal cords were cut longitudinally into 25-mm-thick frozen sections. The sections were collected onto positively charged adhesion slides (SLItech, Lab'IN Co, Hong Kong, China) and dried.
Immunohistochemistry
Longitudinal and transversal nerve sections were washed 3 times in 0.01 M PBS, followed by enzymatic antigen retrieval (incubation with proteinase K [10 mg/mL, Invitrogen] for 10 minutes at 37 C). After 3 more washes, sections were blocked in dilution buffer containing 5% normal donkey serum, 2% of bovine serum albumin (Sigma-Aldrich) and 0.03% of Triton-X-100 (Sigma-Aldrich) in 0.01 M PBS for half an hour at room temperature. Finally, sections were incubated with primary antibody in dilution buffer at 4 C overnight. The following primary antibodies were used: mouse anti-NF200 (1:500, Sigma-Aldrich) for neurofilaments, goat anticholine acetyltransferase (ChAT) (1:100, Merck-Millipore, Billerica, MA) for motoneurons, and rabbit anti-GFP (1:500, Invitrogen) to intensify the signal from the cell graft. After primary antibody incubation, sections were washed 3 times with PBST and incubated with Donkey species-specific secondary antibodies conjugated with the fluorescent label Alexa 568 or 488 (1:400, Invitrogen) for 2 hours at room temperature. After 3 more PBST washes, sections were counterstained with DAPI for 5 minutes at room temperature and mounted in antifade mounting medium (Dako). The slides were observed under a fluorescent microscope (Zeiss Axioplan, Zeiss). Positive and negative controls were used to validate the staining. Positive controls used were noninjured nerve for NF200 staining and noninjured side of the spinal cord for ChAT staining. In some slides, the primary antibody was omitted in immunostaining to serve as a negative control.
Assessment of Survived and Regenerated Motoneurons
Immunohistochemistry on spinal cord sections was performed as described above. Goat anti-ChAT (1:100, MerckMillipore) primary antibody and donkey antigoat Alexa 488 secondary antibody (1:400, Invitrogen) were used to visualize the survived motoneurons in the spinal cord. ChAT is expressed in all motoneurons and was therefore used as a marker for total number of survived motoneurons. Every second longitudinal section (35-40 sections in total) of the C5-C7 spinal cord was stained and motoneurons in the right side of the spinal cord were counted under the fluorescence microscope (Zeiss Axioplan, Zeiss). Motoneurons were counted for all 3 segments together because GDNF might have also affected the neighboring motoneurons in C5 and C7 segments. In some animals, motoneurons were also counted on the noninjured side and averaged to serve as a noninjured control.
Cells that were strongly positive for ChAT with the morphology of motoneurons and clearly visible nucleus were counted. Size was not used as a criterion as motoneuron populations ranged from small (approximately 20 lm diameter) to big (approximately 50 lm in diameter). Stereology was not employed since our tissue sections were relatively thick (25 lm) and only cells with visible nucleus were counted, therefore preventing the duplicative counting. FG had previously been injected into distal nerve to serve as a retrograde tracer. Therefore, motoneurons in spinal cord that were FG-positive represented the cells that had regenerated and extended their axons through reimplanted spinal root all the way to the distal peripheral nerve to where the FG was injected. FG-positive cells were counted for the same slides and sections for all 3 segments together as some motoneurons from C5 and C7 segment were often seen regenerating into the reimplanted C6 roots.
Assessment of Neuromuscular Junctions
Longitudinal sections of the biceps brachii muscle belly were stained with the goat anti-ChAT primary antibody (1:80, Merck-Millipore) according to the protocol above to visualize the motoneuron axons. After overnight incubation with primary antibody, slides were incubated with the donkey antigoat Alexa 568 secondary antibody (1:400, Invitrogen) for 2 hours at room temperature, followed by 30-minute room temperature incubation with Alexa 488-labelled a-bungarotoxin (a-BTX) (1:500, Invitrogen) to visualize postsynaptic acetylcholine receptors of the muscle endplates. The slides were observed under fluorescent illumination using a Zeiss Axioplan microscope (Zeiss). Neuromuscular junctions were analyzed for 4 animals per group, and for each animal, the areas of at least 50 endplates were measured. Furthermore, the percentage of endplates in each treatment group falling into a specific size range (<100, 101-200, 201-300, 301-400, 401-500, 501-600, and <601 mm 2 ) was calculated and distribution curves were drawn. Based on the morphology, they were divided into endplates with normal or abnormal morphology, and the percentage of endplates with normal morphology was calculated. Normal morphology was considered to be pretzellike and with a lot of grooves like in noninjured muscle, whereas the abnormal morphology included endplates with fragmented, shrunken or dispersed appearance.
Assessment of Myelinated Axons
Musculocutaneous nerve samples for groups G1-G4 were taken 2-3 mm proximal to the muscle entering site, whereas in groups G5 and G6 the samples were taken a bit closer to the muscle to make sure it is distal to the cell graft. The samples were fixed in 2% PFA and 2.5% glutaraldehyde in 0.1 M PB at 4 C overnight, postfixed in 1% osmium tetroxide at 4 C for an overnight, dehydrated in serial concentrations of ethanol, infiltrated with propylene oxide, and embedded in Epon. Semithin (0.5 mm) nerve cross sections were cut using a microtome with a glass knife (Leica Ultracut, Leica), and stained with 0.5% toluidine blue in 1% borax for light microscopy (Zeiss Axioplan, Zeiss). The number of myelinated axons per nerve was manually counted in Photoshop CC.
In addition, the diameters of axons together with the myelin sheaths (50 axons per animal) were measured manually using the same software. The percentages of axons falling into each size range (0-2, 2-4, 4-6, . . ., <16 lm) were calculated and are shown on frequency distribution graphs. One nerve sample from G4 group had moved to longitudinal position while embedding and therefore we could not get cross sections for this assessment and it was excluded. Also, 1 sample from G6 group was damaged during processing and the obtained semithin cross sections were not full and had to be excluded from myelinated axonal count assessment.
Histology and Assessment of Muscle Fibers
Cross sections from the midbelly of the biceps brachii (7 mm from the muscle bottom) were stained with hematoxylin and eosin to analyze muscle morphology and to measure muscle fiber areas. Pictures with 20Â and 40Â magnifications under a light microscope (Zeiss Axioplan) were taken for muscle fiber measurements. In each muscle, the individual area of at least 500 muscle fibers across the muscle was measured and the mean was calculated. Results are expressed as percentages calculated by dividing the mean muscle fiber area (mm 
Statistics
To compare the effect of immediate and delayed reimplantation in comparison to no reimplantation after avulsion (G1-G3 groups), parametric one-way ANOVA test with Tukey post hoc correction was used and multiple comparisons were done between each pair (Figs. 2B, 3B, 4B, 7B, 10B, C, and 11B-D). For analyzing the effects of cell and/or GDNF treatment after delayed reimplantation (G3-G6 groups), the same statistical test was used and multiple comparisons were performed versus G3 group (Figs. 2B, 3C , 4C, 7C, 8A, 9B, D, 10B, C, and 11B-D). For smaller sample sizes, as in muscle endplate measurements, nonparametric Kruskal-Wallis test with Dunn's post hoc correction was used to compare multiple groups (Fig. 9B, D) . Axon diameter and endplate area frequency distributions were analyzed with the nonparametric 2-sample Kolmogorov-Smirnov test for frequency distributions (Figs. 8B and 9C ). Behavioral test results were analyzed with 2-way ANOVA with repeated measures in 1 factor in GraphPad software followed by post hoc tests performed with posttest calculator on GraphPad's website (https://www.graphpad. com/quickcalcs/posttest1). Groups were compared pairwise and significant p value for time Â treatment interaction together with subsequent significant differences in post hoc tests were used as the indicators of significant treatment efficiency (Fig. 2C, D) . The difference was considered to be significant if the p value was <0.05. Significant differences are shown with asterisks in the graphs: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. All the results on the graphs are presented as a mean þ SEM (standard error mean). All measurements were performed in a blinded fashion so that the analyst was not aware of the sample origin.
RESULTS
Combination Treatment With GDNF and Cell Transplantation Significantly Improved the Functional Recovery
As the primary aim of this study was to determine whether the combination of ventral root reimplantation, GDNF, and cell treatment results in better functional outcome after avulsion injury, weekly grooming tests were performed. Without the injury, all the animals scored the maximum 5 6 0 (n ¼ 5). When C5-C7 spinal roots were torn off from the spinal cord, all the muscles responsible for elbow flexion movement got denervated (biceps brachii, brachioradialis, and brachialis). Therefore, right after the avulsion injury, almost all animals scored 0-1, whereas no spontaneous improvement was seen without the surgical ventral root reimplantation. However, 4 animals (one each from G2, G3, G5, and G6 groups) scored 2 or more right after the surgery, referring to an incomplete injury, and were therefore excluded from the study. In the animals with repair, functional recovery started from 3 weeks after the reimplantation and the test scores improved from week to week in all reimplanted groups (Fig. 2C, D) . By 12 weeks after the reimplantation, the immediate reimplantation group (G2) showed an average score of 3.6 6 0.2, whereas 2-week delay in reimplantation had lowered the score to 2.4 6 0.6 (G3 group, Fig. 2B ). Significant time Â treatment interaction was seen between G2 and G3 groups (p ¼ 0.0328) (Fig. 2C) , together with the subsequent significant effect at timepoints 10, 11, and 12 weeks after reimplantation. Furthermore, only GDNF or cell treatment did not show any significant improvement (average score of 2.6 6 0.6 and 3.1 6 0.4 at 12-week time point in G4 and G5 group, respectively) compared to the G3 group, whereas combination treatment resulted in better functional recovery (average score 3.7 6 0.2 at 12-week time point). There was no significant main effect of the combination treatment but there was significant time Â treatment interaction between G6 and G3 (p ¼ 0.0015), G4 (p ¼ 0.0066) or G5 (p ¼ 0.0091) groups (Fig. 2B) . Subsequently, post hoc tests revealed the significant differences at timepoints 10, 11, and 12 weeks postrepair between G3 and G6 groups and at 9 and 12 weeks between G4 and G6 groups. In score frequency graphs, both groups with cells, G5 and G6, seemed to have better scores. Namely, at 9 weeks postrepair, more than half of the animals receiving the cell graft scored 3 or 4 (4 out of 7 and 5 out of 7 in G5 and G6 groups, respectively), whereas only 3 out of 7 and 3 out of 8 scored the same in G3 and G4 groups, respectively (Fig. 2E) . By 12 weeks after the repair, most of the animals in the G5 (6 out of 7) and G6 groups (7 out of 7) scored 3 or more by 12 weeks after the reimplantation, whereas only 4 out of 7 and 4 out of 8 animals scored the same in G3 and G4 groups, respectively (Fig. 2F) . Altogether, combination treatment indeed resulted in better functional recovery.
GDNF Helped More Motoneurons Survive Even After the Delayed Repair
In addition to the lost connection between the spinal cord and target muscles after the avulsion, the motoneuron cell bodies also lose their axons. Soon these motoneurons start to die and if there are no cell bodies left then there are also no axons to regenerate. In control group with avulsion injury and no surgical repair (G1 group), only 40% 6 3% motoneurons (1430 6 114) of the contralateral side (3581 6 212 motoneurons in contralateral side) were found in right segments of FIGURE 2. Functional recovery. Grooming test was performed to assess the functional recovery. (A) Grades were given based on the grading scale described in Gu et al (17) as follows: Shortly, 0-no response; 1-flexion at the elbow, not reaching the snout; 2-flexion reaching the snout; 3-reaching below the eyes; 4-reaching to the eyes; and 5-reaching to the ears and beyond. (B) Average grooming test scores 12 weeks after the reimplantation. Forelimb function was restored in all animals with reimplantation. **p < 0.01. The significant difference is shown G1 versus G2-G6. The number of animals in each group is shown inside the bar base. (C) No functional recovery was seen in no repair group (G1). Reimplantation resulted in functional recovery, while the recovery after the immediate repair was significantly better and earlier compared to the delayed one (2-way ANOVA time Â treatment interaction together with subsequent post hoc test results at different timepoints are shown, *p < 0.05). Both G2 and G3 groups were significantly different from the G1 group (asterisks not shown). (D) Only GDNF (G4) or only cell treatment did not improve functional recovery compared to only delayed reimplantation (G3). In contrast, combined treatment with cells and GNDF (G6) showed significantly better functional recovery (significant 2-way ANOVA time Â treatment interaction between G6 and G3, G4 or G5, **p < 0.01). Subsequent significant effects at specific timepoints are shown with asterisks (*) between G3 and G6 groups and with hashtags (#) between G4 and G6 groups. Data are expressed as mean þ SEM (standard error mean). The number of animals in each group is shown inside the bar base. (E, F) More animals with higher test scores were seen in the G5 and G6 groups compared to the G3 and G4 groups. The number of animals with each score in each group is shown in the bar. Results are given for 9 weeks (E) and 12 weeks (F) after the reimplantation (n ¼ 7 in G3, G5, and G6 groups; n ¼ 8 in G4 group). G1-avulsion only; G2-immediate reimplantation; G3-delayed reimplantation; G4-delayed reimplantation þ GDNF; G5-delayed reimplantation þ cells; G6-delayed reimplantation þ cells þ GDNF.
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Treatment of Avulsion Injury C5-C7 in total (Fig. 3A, B) . Immediate ventral root reimplantation (G2 group) showed 49% 6 3% (1738 6 96 motoneurons), whereas the significant difference between G1 and G2 group was not reached (p ¼ 0.06). Interestingly, 2-week delayed reimplantation without any further treatment (G3 group) did not show any prevention of motoneuron death (38% 6 5%, 1360 6 177 motoneurons) compared to the G1 group (Fig. 3A, B) . Therefore, GDNF was used to treat the injury site immediately after the injury, later followed by the 2-week delayed ventral root reimplantation. Immediate topical application of 2 lg GDNF was able to save a lot of motoneurons, reaching 72% 6 6% (2591 6 216 motoneurons) and 60% 6 4% (2151 6 134 motoneurons) in G4 (GDNF only) and G6 (GDNF and cells) groups, respectively (Fig. 3A, C) . Interestingly, although delayed root reimplantation alone (G3 group) did not prevent any motoneuron death, the delayed reimplantation of roots where cells had been injected at the distal side (G5 group) showed similar prevention of motoneuron death (49% 6 4%, 1744 6 148 motoneurons) to immediate ventral root reimplantation (G2 group), however not reaching the statistically significant level (Fig. 3A, C) . 
GDNF Enabled More Motoneurons to Regenerate
In addition to motoneuron cell death prevention, surgical repair was performed to allow these survived motoneurons to regenerate and extend their axons into the spinal nerve and toward the target muscle. For surgical repair, C6 ventral spinal roots that had been avulsed and ligated were reimplanted onto the spinal cord immediately or 2 weeks after the avulsion injury to resemble delay happening in reality. ChAT-positive axons were seen to extend from the spinal cord to the reimplanted roots at the CNS and PNS interface in all reimplanted groups (Supplementary Data Fig. 1 ). Regenerated motoneurons were further retrogradely labeled with FG that was injected into the distal part of the musculocutaneous nerve a few days before death. FG-positive motoneurons were counted on the same slides as ChAT-positive motoneurons for all 3 Immediate reimplantation (G2) was more effective compared to the delayed one (G3) and enabled more motoneurons to regenerate. ****p < 0.0001. (C) GDNF treatment (G4 and G6) enabled more motoneurons to regenerate, whereas cells did not have much effect. Differences are shown versus G3 group. *p < 0.05. G1-avulsion only, G2-immediate reimplantation, G3-delayed reimplantation, G4-delayed reimplantation þ GDNF, G5-delayed reimplantation þ cells, G6-delayed reimplantation þ cells þ GDNF. Data are expressed as mean þ SEM. The number of animals in each group is shown inside the bar base.
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Treatment of Avulsion Injury segments (C5-C7) together. As expected, almost no regenerated motoneurons were seen in G1 group, where no root reimplantation was performed (15 6 7 motoneurons) (Fig. 4A, B) . Ventral root reimplantation, however, enabled survived motoneurons from mostly around C6 segment to regenerate into the reimplanted roots and spinal nerve (Fig. 4A) . In some cases, FG-positive motoneurons were also seen at the C5 or C7 segments. Immediate ventral root reimplantation (G2 group) helped 748 6138 motoneurons to regenerate, whereas 2-week delayed reimplantation (G3 group) resulted only in 95 6 38 regenerated motoneurons (Fig. 4A, B) . Moreover, as GDNF treatment combined with delayed reimplantation helped more motoneurons survive, it also helped more of them to regenerate. In G4 group (GDNF only), 363 6 97 motoneurons regenerated and in the G6 group (GDNF and cells) 414 6 92 motoneurons regenerated (Fig. 4A, C) . However, cell graft into distal nerve did not affect motoneuron regeneration compared to the G3 group, even though slightly more regenerated motoneurons were seen (162 6 26 motoneurons) (Fig. 4A, C ).
More Regenerated Axons Were Seen in the Distal Nerve After GDNF Treatment
As reimplantation proved to be effective in allowing motoneurons to regenerate into the spinal nerve, regenerated axons in distal nerve were visualized by NF200 immunostaining. Almost no axons were seen in G1 group, whereas longitudinal nerves from all reimplanted groups showed NF200-positive axons (Fig. 5A) . The distal nerve cross sections from animals receiving cell transplantation (G5 and G6 group) showed axons from 2 different origins: (1) host regenerated axons (GFP-negative/NF200-positive), and 2) axons from grafted cells (GFP-positive/NF200-positive) (Fig. 5B) . As these fetal lumbar cells were mostly newly born neurons at the isolation and transplantation time (Fig. 6A) , they had also kept their neuronal identity in vivo (Fig. 6B) . However, as also seen in our previous studies with the same cells (64), GFP expression had weakened a lot and in most of the animals, grafted cells showed GFP expression only in the cell bodies and not in the axons. As a result, it was not possible to do the quantification of how many of the axons were the host and how many of them were of the graft origin. However, for further axon quantification, semithin nerve cross sections were stained with toluidine blue and a total number of myelinated axons in very distal part of the musculocutaneous nerve were counted. Almost no axons were seen in G1 group nerves (14 6 6 axons, 2% of contralateral), whereas all reimplantation groups showed successfully regenerated axons (Fig. 7A, B) . Contralateral noninjured nerve from the same location showed around 885 6 130 axons (100%, n ¼ 3). After immediate ventral root reimplantation (G2 group), approximately 772 6 133 axons (87% 6 15%) were seen, which is almost triple of the number seen after 2-week delayed reimplantation (G3 group) (268 6115 axons, 30% 6 13%) (Fig. 7A, B) . As GDNF treatment groups showed more regenerated motoneurons, they also showed more myelinated axons in the distal nerve (947 6 235 axons [107% 6 27%] in G4 group and 904 6 183 axons [102% 6 21%] in G6 group) (Fig. 7A, C) . Interestingly, the number of axons was similar in the G4, G6, and G2 groups (Fig. 7B) , whereas G4 and G6 had much less retrogradely labeled motoneurons compared to the G2 group (Fig. 4C) . Therefore, GDNF had enhanced the axonal sprouting. However, cell treatment alone (G5) did not show significantly more axons (375 6 67 axons, 42% 6 8%) compared to the G3 group (Fig. 7C) . Size-wise, the biggest axons were seen in the immediate reimplantation group (G2 group, average axon diameter 5.93 6 0.64 lm) (Figs. 7A and 8A) . Delay in the reimplantation resulted in slightly smaller axons (G3 group, FIGURE 5 . Regenerating axons in distal nerve sections. (A) Antibody against NF200 was used to visualize axons in longitudinal distal musculocutaneous nerve sections. Nerves from the animals without ventral root reimplantation (G1 group) showed almost no NF200-positive axons, while reimplantation enabled a lot of axons to regenerate into the distal nerve (G2-G6 groups). G1-avulsion only; G2-immediate reimplantation; G3-delayed reimplantation; G4-delayed reimplantation þ GDNF; G5-delayed reimplantation þ cells; G6-delayed reimplantation þ cells þ GDNF. (B) Both transplanted-cellderived axons (GFP-positive/NF200-positive) and host regenerating axons (GFP-negative/NF200-positive) were seen in the distal nerves of cell-grafted animals from the G5 (delayed reimplantation þ cells) and G6 groups (delayed reimplantation þ cells þ GDNF). A representative picture is shown for an animal from G5 group. 5.21 6 0.50 lm), though the difference in average axon diameter was not significant. Also, GDNF did not have any effect on axon size (G4 group, 5.00 6 0.44 lm) (Fig. 8A) . However, average axon size in groups with cell transplantation was slightly but not significantly smaller (4.06 6 0.34 and 4.07 6 0.18 lm in G5 and G6 groups, respectively) (Fig. 8A) , because these nerves were expected to also contain axons from grafted cells that might have been smaller compared to the host axons. No statistically significant differences were seen between the average axon diameters from delayed reimplantation groups with different treatments (G3-G6) (Fig. 8A) . However, when all measured axons were added to frequency distribution graphs, axons in animals with immediate reimplantation (G2) had been shifted to bigger axon range in comparison to the delayed reimplantation groups (G3-G6). Also, both groups with cell transplantation (G5 and G6) had shifted to smaller axon range compared to groups G2, G3, and G4 (Fig. 8B) .
Ventral Root Reimplantation Resulted in Reformed Neuromuscular Connections
Next, because ventral root reimplantation and some treatments affected axon regeneration, the effect of these axons on muscle endplates was investigated. Muscle endplates had degenerated to some extent in all the groups, showing either shrunken, dispersed or fragmented appearance as was seen in degenerating endplates. However, ventral root reimplantation had led to the reformation of connections between the axons and muscle endplates, whereas the avulsion-only group did not show any continuous connections (Fig. 9A) . After some of the endplates were successfully reinnervated by axons from either host or cell graft, they returned to their normal pretzel-like morphology. In G1 group (avulsion only), only 12% 6 4% of the endplates showed normal-like morphology, whereas immediate reimplantation (G2 group) resulted in 32% 6 8% of normal-like endplates (Fig. 9D) . The 2-week delay in reimplantation (G3 group) resulted in 10% less normal endplates (22% 6 4%), whereas GDNF treatment, cell transplantation, and combination of these 2 all helped to prevent this loss of endplates caused by the delay (32% 6 7%, 31% 6 6%, 36% 6 4% of normal endplates in G4, G5, and G6 groups, respectively) (Fig. 9D) . However, the differences were not statistically significant due to small sample sizes. Moreover, average endplate size was slightly but not significantly increased by the ventral root reimplantation (G2 group, 270 6 11 lm 2 ) compared to the avulsion-only group (G1 group, 210 6 25 lm 2 ), whereas delayed reimplantation groups with or without treatments showed similarly sized endplates (G3 group, 255 6 33 lm , and G6 group 248 6 9 lm 2 ) (Fig. 9B) . Injury had caused the decrease in endplate size in all the groups, as endplates in contralateral noninjured side were approximately 315 6 14 lm 2 (Fig. 9B) . According to the endplate area frequency distribution graphs, only the G1 and noninjured group were statistically different from all the rest (Fig. 9C) .
Ventral Root Reimplantation Helped Muscles Gain EMG Responsiveness
To test the functionality of seen neuromuscular junctions, EMG was performed 3-5 days before death and right before the FG injection. In the G1 group without the reimplantation, nerve stimulation resulted in a weak response FIGURE 7 . Myelinated axons in the distal nerve. Axons were able to regenerate into the reimplanted root and extend further in the nerve. (A) Semithin cross sections from distal musculocutaneous nerve were stained with toluidine blue to visualize all myelinated axons. Representative images of every group are shown. (B) Immediate ventral root reimplantation (G2) resulted in more extending axons compared to the delayed reimplantation group (G3). **p < 0.01, ****p < 0.0001. (C) GDNF treatment (G4 and G6) enabled more axons to regenerate and it enhanced the axonal sprouting compared to the only delayed reimplantation group (G3). Differences are shown versus G3 group. *p < 0.05. G1-avulsion only; G2-immediate reimplantation; G3-delayed reimplantation; G4-delayed reimplantation þ GDNF; G5-delayed reimplantation þ cells; G6-delayed reimplantation þ cells þ GDNF. Percentages are calculated by dividing the myelinated axon number of each nerve with the average of contralateral noninjured side group (n ¼ 3). Data are expressed as mean þ SEM. The number of animals in each group is shown inside the bar base.
with a long delay in the biceps brachii muscle (amplitude of 0.44 6 0.12 mV, response delay 2.10 6 0.16 ms) (Fig. 10A-C) . As reimplantation had enabled host axons to regenerate and form neuromuscular junctions, all animals in groups G2-G6 were able to show good EMG responsiveness (Fig. 10A) . Average EMG response amplitudes in reimplantation groups (G2-G6) were statistically indifferent from each other (1.68-2.33 mV) while being around half of the noninjured muscle amplitude (4.64 6 0.36 mV) (Fig. 10B) . Average response delays in muscles were also similar in all of the reimplanted groups (1.23-1.47 ms) (Fig. 10C) . Therefore, only reimplantation was needed to regain the EMG responsiveness, whereas the delay in reimplantation and different treatments did not have any further effect.
Cell Transplantation Helped Prevent Muscle Atrophy
As slightly better-looking muscle endplates were seen after cell and/or GDNF treatment, the condition of the target muscles was assessed next (Fig. 11A) . Muscles without any repair (G1 group) had only retained 31% 6 2% of their weight, 18% 6 2% of their cross-sectional area and 23% 6 4% of their fiber size (Fig. 11B-D) . Even though muscle atrophy still occurred with the surgical repair (Fig. 11A) , it was less severe and muscles with immediate reimplantation were around double the size of G1 group muscles (G2 group, 51% 6 2% of retained muscle weight, 36% 6 4% of retained cross-sectional area, and 49% 6 6% of retained fiber size) (Fig. 11B-D) . The 2-week delay in reimplantation caused a slight decrease (not statistically different) in all muscle atrophy measurements (G3 group, 45% 6 3% of retained muscle weight, 32% 6 5% of retained cross-sectional area, and 38% 6 4% of retained fiber size) compared to the immediate reimplantation (Fig. 11B-D) . GDNF treatment (G4 group) had slight but not significant positive effect on muscle atrophy (54% 6 3% of retained muscle weight, 40% 6 4% of retained cross-sectional area, and 50% 6 5% of retained fiber size), whereas cell treatment (G5 group) enhanced the muscle condition significantly (57% 6 5% of retained muscle weight, 40% 6 6% of retained cross-sectional area, and 58% 6 7% of retained fiber size) (Fig. 11B-D) . Interestingly, GDNF and cell combined treatment did not have even a slight effect on muscle atrophy (52% 6 2% of retained muscle weight, 33% 6 2% of retained cross-sectional area, and 41% 6 4% of retained fiber size) compared to the G3 group (Fig. 11B-D) .
DISCUSSION
How Is GDNF Beneficial After Avulsion Injury?
In contrast to the distal peripheral nerve injury, avulsion injury also causes damage to the CNS. More precisely, motoneurons tend to die when their axons are torn off too close to the cell body. Motoneuron death is shown to involve both apoptotic and necrotic pathways (65) (66) (67) (68) (69) (70) (71) . Peripheral nerve graft or reimplantation of original nerve roots has shown to prevent part of the motoneuron loss, as they most likely act through the production of neurotrophic factors (72) (73) (74) (75) . However, these surgical repairs do not show full prevention of motoneuron death and therefore exogenous neurotrophic factor application can be considered. Many different neurotrophic factors have shown to help motoneurons to survive, whereas GDNF is the most promising one (10-13, 76, 77) . Because GDNF treatment has been effective only when applied within 2 weeks postinjury, in this study it was applied topically to the spinal cord immediately after the injury. Unlike in other studies, this immediate GDNF treatment was combined with 2-week delayed root reimplantation in order to determine whether motoneurons saved by GDNF are able to regenerate after some delay. As expected, GDNF saved a lot of motoneurons from the death, keeping them alive up to 3.5 months after the injury. In the current study, roots from 3 spinal cord segments were avulsed, but only the C6 segment was treated with GDNF and reimplanted with the avulsed roots. As more motoneurons survived with GDNF treatment, more of them also regenerated into the ventral roots after the delayed surgical repair. Interestingly, there were still more regenerating motoneurons in immediate reimplantation group (G2 group-748 regenerated motoneurons) compared to the GDNF groups with delayed repair (G4 group-363 regenerated motoneurons, G6 group-414 regenerated motoneurons) (Fig. 4) , even though the GDNF groups showed much more survived Treatment of Avulsion Injury motoneurons (2591/2151 compared to 1738 survived motoneurons in G4/G6 and G2 groups, respectively) (Fig. 3) . Thus, the delay in surgical repair had seriously compromised the regeneration capability of the survived motoneurons. Additionally, in contrast to fewer regenerated motoneurons in G4 and G6 groups compared to the G2 group, the number of total axons in distal nerve was slightly higher in the G4 (947 axons) and G6 groups (904 axons) compared to the G2 group (772 axons) (Fig. 7) . This phenomenon proves that GDNF had not only helped the motoneurons to survive and regenerate but also enhanced the axonal sprouting. Due to more regenerating axons, more of them also reached the muscles, resulting in a slight prevention of muscle atrophy compared to the delayed repair only group (G3) (Fig. 11) . However, GDNF treatment did not show any effect on behavioral recovery.
How Do Lumbar FSC Cells Help After Avulsion Injury?
As our previous study showed that the transplantation of embryonic spinal cord fetal cells mitigated muscle atrophy after peripheral nerve transection (64) , this study was done to investigate the effect of the same cells in more severe avulsion injury model. Reduction in muscle atrophy was also seen in this model when cells were applied alone without the GDNF treatment; however, the treatment effect was less prominent compared to the peripheral nerve transection model (64) .
The avulsion injury was more severe compared to the musculocutaneous nerve transection and it included the damage to all the nerves arising from C5-C7 spinal cord segments. As ventral spinal roots were reimplanted to the spinal cord, it enabled the survived motoneurons to grow their axons into the ventral roots and extend and reinnervate the target muscle. Due to the reformed connection between the spinal cord and target muscle, it was possible to analyze the functional recovery. Enhancing and speeding up the functional recovery is the main focus of this kind of translational studies. Based on the results, combining the cell transplantation with GDNF treatment led to significantly improved functional recovery. As cell transplantation mainly helped with muscle atrophy, providing host regenerating axons with healthier muscles upon arrival, the GDNF treatment supplied a supplementary number of functional motor neurons that contributed to the improvements observed (Fig. 2) .
As cells were grafted close to the muscle, they were believed to reinnervate the muscle endplates shortly after the injury, thereby preventing their degeneration till the host axons was regenerating after the delayed surgical repair. This study had only one time point, when most of the host regenerating axons had already reached the muscle fibers in addition to the grafted cells. Due to the 2 origins of new axons, muscles were reinnervated by more axons and the differences in muscle condition between groups with cells and without cells were smaller than would have been without repair. It might have FIGURE 9 . The size and morphology of muscle endplates. (A) Animals with ventral roots reimplantation showed some connections between muscle endplates (a-BTX in green) and axons (NF200, red), while no connections were seen in the avulsion-only group (G1). (B) Ventral root reimplantation resulted in slightly but not significantly bigger muscle endplates, while no differences were seen between different treatment groups. (C) Frequency distribution of muscle endplate sizes. *p < 0.05. (D) No significant differences were seen between reimplanted groups; however, delayed repair with no treatment showed slightly less normal-looking endplates. G1-avulsion only; G2-immediate reimplantation; G3-delayed reimplantation; G4-delayed reimplantation þ GDNF; G5-delayed reimplantation þ cells; G6-delayed reimplantation þ cells þ GDNF. Data are expressed as mean þ SEM. The number of animals in each group is shown inside the bar base.
been beneficial to add an earlier time point, where only grafted cells, and not host axons, had reached the muscles. In that case, more severe muscle atrophy, similar to the avulsion-only group (G1), would have been expected in animals with no cells. However, we had shown this phenomenon in our previous study in which no surgical repair was performed (64) , allowing only the grafted cells to reinnervate the muscles.
As grafted cells over time seemed to preserve the weak GFP expression only in the cell bodies and not in the axons, it was quite difficult to trace them and determine how far the axons were extended in the nerve and whether they formed the connections with the muscle endplates. Therefore, it was not always possible to distinguish the host axons from the grafted cells. However, in some cases the GFP expression was distinguishable, and both grafted cells and host axons were seen distal to the cell graft in the nerve (Fig. 5) . The number of total axons in the distal nerve was not affected by the cell graft (no difference between G3 and G5 nor between G4 and G6) (Fig. 7) , even though the increase in axon number could have been expected due to the 2 origins for the axons. However, transplanted cells were often seen as a large group of cells that together might have acted as a barrier to host regenerating axons that might not have been able to pass the cell graft so easily. Also, the average axon size in the distal nerve was FIGURE 10. EMG assessment. Ventral root reimplantation restored EMG responsiveness. (A) Representative images of EMG response seen in biceps brachii after distal part of musculocutaneous nerve was stimulated. (B) Average EMG response altitudes showed no significant differences between reimplanted groups (G3-G6), while all these responses were significantly higher than in G1 group and significantly lower than in the noninjured group. *p < 0.05, **p < 0.01. (C) Average EMG response delay is shown in milliseconds as a time from the stimulus to response. No differences were observed between reimplanted groups (G3-G6), while all the reimplanted groups had shorter response delay than the G1 group and longer delay compared to the noninjured side. **p < 0.01. The differences are shown G1/noninjured versus G2-G6. G1-avulsion only; G2-immediate reimplantation; G3-delayed reimplantation; G4-delayed reimplantation þ GDNF; G5-delayed reimplantation þ cells; G6-delayed reimplantation þ cells þ GDNF. Data are expressed as mean þ SEM. The number of animals in each group is shown inside the bar base.
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Treatment of Avulsion Injury FIGURE 11. Muscle atrophy assessment. (A) Representative pictures of muscle fibers stained with the hematoxylin-eosin method. Muscles were assessed for their average fiber size (B), wet weight (C), and cross-sectional area (D). Ventral root reimplantation (G2 and G3) helped to prevent muscle atrophy, while the delay in reimplantation (G3) resulted in slightly but not significantly more muscle atrophy compared to the immediate reimplantation (G2). Cell transplantation (G5) was effective at preventing muscle atrophy, resulting in bigger muscle fibers. Differences in the graphs on the right side are shown versus G3 group. *p < 0.05, **p < 0.01, ***p < 0.001. G1-avulsion only; G2-immediate reimplantation; G3-delayed reimplantation; G4-delayed reimplantation þ GDNF; G5-delayed reimplantation þ cells; G6-delayed reimplantation þ cells þ GDNF. Data are expressed as mean þ SEM. The number of animals in each group is shown inside the bar base.
decreased in groups with cell graft because very likely the grafted cells had smaller axons than the host motoneurons, thus lowering the average axon size (Fig. 8) .
One could argue that because grafted cells were injected very distally into the nerve, they should not have affected the motoneuron cell bodies in the spinal cord. Even though the slight increase in motoneuron survival (from 1360 [G3] to 1744 [G5] survived motoneurons) caused by cell graft was not significant and might be due just to the variation, this seen phenomenon could still be discussed. As transplanted cells also produce different neurotrophic factors, this might have been how they influenced the motoneurons in spinal cord even over the long distance; however, these exact mechanisms are yet to be investigated.
How Effective Is Combined Treatment With GDNF and Cells?
While cell transplantation and GDNF treatment alone were both able to affect different aspects of the recovery, the combination of these 2 treatments led to slightly different results in some of the assessments. In contrast to GDNF-only or cells-only treatment, combined treatment resulted in significantly better functional recovery. This shows that both-more regenerating axons and muscles reinnervated earlier-were needed to actually obtain a relevantly improved functional outcome. Surprisingly, these animals did not show any improvement in the muscle condition that was seen in cells only (G5) group. It might be because with the GDNF treatment, it is believed that regenerating axons are at first trapped in GDNF-rich areas and therefore they might have reached the muscles later in G6 group compared to G5 group, resulting in less improvement in muscle condition.
In contrast, cell transplantation seemed to slightly compromise the positive effects of GDNF treatment. Even though cell therapy alone had a slightly positive or no effect on motoneuron survival, it turned out to be a slightly inhibitory when added to the GDNF treatment. More precisely, adding cell transplantation to the GDNF treatment slightly reduced the number of survived motoneuron (2151 survived motoneurons) in comparison to only GDNF treatment (2591 survived motoneurons), even though the difference was not significant and therefore can be just due to the variation. However, if that is not the case, then the reason behind this phenomenon is unknown and could be investigated. As the cells were transplanted in the distal nerve close to the muscle and far from the spinal cord, they must have influenced the motoneurons probably through the neurotrophic effect. When only cells were injected, this neurotrophic effect was slightly positive to motoneuron survival. However, when cell transplantation was combined with the application of exogenous GDNF, it might have caused either a slight "overdose" of this neurotrophic factor, or other neurotrophic factors produced by the grafted cells could have been an antagonist to GDNF, resulting in a slightly inhibitory effect. Altogether, even though the cell transplantation in the combined treatment might have slightly inhibited the GDNF's effect on motoneuron survival, this compromise should be made in order to benefit from the earlier functional recovery that is the goal for this kind of treatment.
